Live Quote · NYSEABBVHealthcare· Drug Manufacturers - General

AbbVie Inc.

$286.20▲ 0.94%(+$2.66)
MKT CAP $505.89BNEXT EARNINGS Feb 3, 2027
50%
Bullish
TickerSpark Score
67/100
▌ Solid
64
Valuation
75
Profitability
40
Growth
56
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABBV research report →

Analyst Price Target
$316.87+10.7% vs. today

Range $275 – $349

Analyst RatingBuy
31 Buy12 Hold1 Sell

Price Chart

+25.92% · this period
$295.03$246.20$197.38Nov 20May 26Nov 20
52-Week Range85% of range
Low
$190.75
Current
$286.20
High
$302.93

AI analysis · Last refreshed November 17, 2026 · Live quote · Not investment advice